”2'-O-methyl nucleotide modified DNA substrates influence the cleavage efficiencies of BamHI and BglII”. Journal of Biosciences 39 (4): sid. 621–30. September 2014. doi:10.1007/s12038-014-9466-4. PMID 25116617.
”The role of metals in catalysis by the restriction endonuclease BamHI”. Nature Structural Biology 5 (10): sid. 910–6. October 1998. doi:10.1038/2352. PMID 9783752.
”Why do divalent metal ions either promote or inhibit enzymatic reactions? The case of BamHI restriction endonuclease from combined quantum-classical simulations”. The Journal of Biological Chemistry 278 (7): sid. 4381–4. February 2003. doi:10.1074/jbc.C200664200. PMID 12496295.
”Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromes”. Gene Therapy 15 (7): sid. 516–23. April 2008. doi:10.1038/sj.gt.2008.11. PMID 18256697.
nih.gov
ncbi.nlm.nih.gov
”2'-O-methyl nucleotide modified DNA substrates influence the cleavage efficiencies of BamHI and BglII”. Journal of Biosciences 39 (4): sid. 621–30. September 2014. doi:10.1007/s12038-014-9466-4. PMID 25116617.
”The role of metals in catalysis by the restriction endonuclease BamHI”. Nature Structural Biology 5 (10): sid. 910–6. October 1998. doi:10.1038/2352. PMID 9783752.
”Why do divalent metal ions either promote or inhibit enzymatic reactions? The case of BamHI restriction endonuclease from combined quantum-classical simulations”. The Journal of Biological Chemistry 278 (7): sid. 4381–4. February 2003. doi:10.1074/jbc.C200664200. PMID 12496295.
”Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromes”. Gene Therapy 15 (7): sid. 516–23. April 2008. doi:10.1038/sj.gt.2008.11. PMID 18256697.
